ALR Technologies SG (ALRTF) Return on Equity (2024 - 2025)

ALR Technologies SG posted quarterly Return on Equity of 0.0% for Q4 2025, little changed year-on-year from 0.0% in Q4 2024, and down 4.65% on a QoQ basis from 0.0% in Q2 2025.

ALR Technologies SG (ALRTF) has 2 years of Return on Equity data on file, last reported at 0.0% in Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
  • Return on Equity for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q2 2025 and bottomed at 0.0% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.00%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.00%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 ALR Technologies SG - - - 0.00%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.00%
Jun 30, 2025 0.00%
Dec 31, 2024 0.00%